功能变异对缺血性中风患者与心房的长期预后的影响
Xiao Wang1, Chun-Fung Sin2, Kay-Cheong Teo1
1Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Frontiers in neurology
|May 7, 2024
概括
在中风后患有心房动 (AF) 的患者中,功能变化增加了中风复发,出血和死亡的风险. 这一发现凸显了监测高风险人群中功能波动的重要性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 神经学 神经学
背景情况:
- 功能障碍是心房动 (AF) 患者中风后不良结果的已知危险因素.
- 功能变异对该人群临床结果的具体影响尚不清楚.
研究的目的:
- 研究患有过渡性缺血性攻击 (TIA) /缺血性中风和AF的患者的功能变异性和不良临床结果之间的关联.
- 在这个患者队列中,量化与估计膜过率 (eGFR) 的不同水平相关的风险.
主要方法:
- 一项基于人口的回顾性研究,使用香港临床数据分析和报告系统 (2016-2020).
- 包括被诊断为TIA/缺血性中风和AF的患者,并进行连续血清肌氨酸测量.
- 使用eGFR变化系数计算功能变化;使用竞争风险和Cox回归模型分析临床终点,包括中风,出血,出血,MACE和死亡率.
主要成果:
- 一组3809名患者 (平均年龄80岁) 平均被跟踪了2.5年.
- 较大的eGFR可变性与复发性缺血性中风/全身栓塞,脑内出血 (ICH),总出血,主要不良心血管事件 (MACE) 和全因死亡率的风险增加显著相关.
- 具体的完全调整的危险比率表明,中风 (1.11),ICH (1.17),出血 (1.13),MACE (1.22) 和死亡率 (1.44) 的风险增加,EGFR变异性更大.
结论:
- 访客对访客的功能变异性是TIA/缺血性中风AF患者不良临床结果的独立预测因素.
- 这些发现强调了监测功能波动的临床意义.
- 建议进行进一步的大规模研究来验证这些结果.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
90
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
90
Renal Failure: Dose Adjustments
85
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
85
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: Diuretics
367
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
367
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
57
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
57
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
212
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
212


